Literature DB >> 17676865

Effects of diosmin, a flavonoid glycoside in citrus fruits, on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 cells.

Hye Hyun Yoo1, Mijin Lee, Hye Jin Chung, Sang Kyu Lee, Dong-Hyun Kim.   

Abstract

The effects of citrus flavonoids on P-glycoprotein (P-gp)-mediated drug efflux were examined in human intestinal Caco-2 cells. The cellular accumulation of rhodamine-123 was measured using 10 citrus flavonoids for preliminary screening. Among the flavonoids tested, diosmin significantly increased the accumulation of rhodamine-123 in Caco-2 cells. In the bidirectional transport of digoxin, diosmin increased the apical-to-basal (A-to-B) transport but decreased the basal-to-apical (B-to-A) transport in both concentration- and time-dependent manners. The digoxin transport ratio (B-A/A-B) was estimated to be 2.3 at a concentration of 50 microM of diosmin, which was significantly lower than the 15.2 found in the control. The apparent Ki values for P(app,A-B) and P(app,B-A) were 16.1 and 5.7 microM, respectively. These results demonstrated that diosmin effectively inhibited the P-gp-mediated efflux in Caco-2 cells. Diosmin is one of the main components in citrus fruits, and the intake of food supplements containing this compound may potentially increase the absorption of drugs able to act as P-gp substrates. The clinical relevance of this interaction should be further evaluated using in vivo experiments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17676865     DOI: 10.1021/jf070893f

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  4 in total

Review 1.  Recent advances in valorization of citrus fruits processing waste: a way forward towards environmental sustainability.

Authors:  Shweta Suri; Anupama Singh; Prabhat K Nema
Journal:  Food Sci Biotechnol       Date:  2021-10-07       Impact factor: 3.231

2.  Berry anthocyanins and anthocyanidins exhibit distinct affinities for the efflux transporters BCRP and MDR1.

Authors:  A Dreiseitel; B Oosterhuis; K V Vukman; P Schreier; A Oehme; S Locher; G Hajak; P G Sand
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

3.  The effect of Crataegus oxycantha Special Extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure.

Authors:  Suzanna M Zick; Brenda Gillespie; Keith D Aaronson
Journal:  Eur J Heart Fail       Date:  2008-05-19       Impact factor: 15.534

4.  Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents.

Authors:  Michael Wink; Mohamed L Ashour; Mahmoud Zaki El-Readi
Journal:  Front Microbiol       Date:  2012-04-23       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.